Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Drugs & Targets

Foundation Medicine and Day One Biopharmaceuticals form collaboration focused on pediatric cancer care

September 23, 2022
Vol.48 No.34
Drugs & Targets

FDA approves Imbruvica for pediatric cGVHD

September 09, 2022
Vol.48 No.32
In Brief

St. Jude expands strategic plan to target pediatric catastrophic diseases

July 15, 2022
Vol.48 No.28
Clinical Roundup

NCCN publishes new recommendations for treating children with brain tumors

July 15, 2022
Vol.48 No.28
Neuroblastoma researcher Robert C. Seeger dies at 82
FreeObituary

Neuroblastoma researcher Robert C. Seeger dies at 82

June 17, 2022
Vol.48 No.24
By Katherine K. Matthay, Judith G. Villablanca, C. Patrick Reynolds and John M. Maris
Clinical Roundup

Five-year Kymriah data show durable remission, long-term survival in advanced B-cell ALL

June 17, 2022
Vol.48 No.24
Clinical Roundup

FIREFLY-1 trial of DAY101 in relapsed pLGG shows positive initial data

June 17, 2022
Vol.48 No.24
Lucius Sinks, a giant in pediatric cancer, dies at 91
FreeObituary

Lucius Sinks, a giant in pediatric cancer, dies at 91
“We were able to come together at Roswell Park and help the kids.”

June 10, 2022
Vol.48 No.23
By Tim Wendel
Lucius Sinks was the type of physician all of us would like to have
FreeObituary

Lucius Sinks was the type of physician all of us would like to have

June 10, 2022
Vol.48 No.23
By Jerome Yates
FreeIn Brief

WHO and St. Jude form $200M collaboration to increase global access to childhood cancer medicines

December 13, 2021
Vol.47 No.46

Posts navigation

Previous1…789Next

Trending Stories

  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Charles Rudin named cancer center director at MSK
  • How City of Hope is turning microbiome science into better cancer care
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use
  • What are you reading in 2024?

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account